医药稳健科研股策略:年化收益率（31.25%）
本策略精选医药生物行业中研发投入高、净利润快速增长、估值合理的优质股票。通过量化财务指标，筛选出具备持续成长潜力的标的，并定期轮动调仓，力求在医药行业中获取稳健收益。
概要
核心指标
- 累计收益率: 64.62%
- 年化收益率: 31.25%
- 基准收益率: 9.45%
- 阿尔法: 0.28
- 夏普比率: 1.03
- 最大回撤: 22.06%
源码
查看AI策略代码
绩效
持仓详情
|
当日收盘价 | 当日市值 | 浮动收益/浮动收益率
|
|||||
|---|---|---|---|---|---|---|---|
| 2025-08-06 | 亚宝药业(600351.SH) | 5.8502682259687 | 69630 | 66 | 7.75 | 539632.5 | 132278.32/32.473% |
| 2025-08-06 | 国药现代(600420.SH) | 10.138724132856 | 45708 | 66 | 11.27 | 515129.16 | 51708.36/11.158% |
| 2025-08-06 | 浙江医药(600216.SH) | 13.773307072107 | 35090 | 96 | 15.77 | 553369.3 | 70063.95/14.497% |
| 2025-08-05 | 亚宝药业(600351.SH) | 5.8502682259687 | 74330 | 65 | 8.01 | 595383.3 | 160532.86/36.917% |
| 2025-08-05 | 国药现代(600420.SH) | 10.128008357566 | 45308 | 65 | 11.36 | 514698.88 | 55819.08/12.164% |
| 2025-08-05 | 浙江医药(600216.SH) | 13.725877665798 | 34290 | 95 | 15.86 | 543839.4 | 73179.05/15.548% |
| 2025-08-04 | 亚宝药业(600351.SH) | 5.8502682259687 | 74330 | 64 | 7.96 | 591666.8 | 156816.36/36.062% |
| 2025-08-04 | 国药现代(600420.SH) | 10.128008357566 | 45308 | 64 | 11.44 | 518323.52 | 59443.72/12.954% |
| 2025-08-04 | 浙江医药(600216.SH) | 13.725877665798 | 34290 | 94 | 15.86 | 543839.4 | 73179.05/15.548% |
| 2025-08-01 | 亚宝药业(600351.SH) | 5.8502682259687 | 74330 | 63 | 7.95 | 590923.5 | 156073.06/35.891% |
交易详情
| 2025-08-06 | 浙江医药(600216.SH) | 买 | 800 | 15.8 | 12640 | ¥5 | 0 |
| 2025-08-06 | 国药现代(600420.SH) | 买 | 400 | 11.34 | 4536 | ¥5 | 0 |
| 2025-08-06 | 亚宝药业(600351.SH) | 卖 | -4700 | 8.01 | -37647 | ¥48.94 | 10150.74 |
| 2025-07-30 | 浙江医药(600216.SH) | 买 | 600 | 15.43 | 9258 | ¥5 | 0 |
| 2025-07-30 | 国药现代(600420.SH) | 买 | 200 | 11.39 | 2278 | ¥5 | 0 |
| 2025-07-30 | 亚宝药业(600351.SH) | 卖 | -2400 | 7.22 | -17328 | ¥22.53 | 3287.36 |
| 2025-07-23 | 浙江医药(600216.SH) | 买 | 700 | 15.1 | 10570 | ¥5 | 0 |
| 2025-07-23 | 国药现代(600420.SH) | 买 | 100 | 11.11 | 1111 | ¥5 | 0 |
| 2025-07-23 | 亚宝药业(600351.SH) | 卖 | -1800 | 6.63 | -11934 | ¥16.93 | 1403.52 |
| 2025-07-21 | 浙江医药(600216.SH) | 买 | 790 | 15.08 | -0.8 | ¥0 | 0 |
